<DOC>
	<DOCNO>NCT02524223</DOCNO>
	<brief_summary>Human PapillomaVirus ( HPV ) one main causal agent sexually transmit disease . Numerous HPV genotype 16 , 18 , 31 45 consider high risk oncogenicity especially anal cervical mucosa . At present time , recommendation exist risk relate HPV Medically Assisted Procreation ( MAP ) procedure . The main objective prospective multicentric cohort study evaluate prevalence transmission HPV via semen MAP program . Secondary objective evaluate ( 1 ) prevalence HPV DNA sperm fraction men enrol MAP , ( 2 ) efficacy spermatozoal pellet preparation procedure eliminate HPV , ( 3 ) correlation HPV male infertility ( 4 ) correlation HPV success rate procreation . Results could contribute revise guideline MAP procedure HPV vaccination policy .</brief_summary>
	<brief_title>Prevalence HPV Transmission During Medically Assisted Procreation Procedures</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Age 18 Age 40 woman Signed informed consent member couple Medical indication MAP AI ( artificial insemination ) , IVF ( vitro fertilization ) ICSI ( intracytoplasmic sperm injection ) method Well understand information letter Age 40 woman Informed consent form sign one partner Coinfection one partner HIV ( human immunodeficiency virus ) , HBV ( hepatitis B virus ) and/or HCV ( hepatitis C virus ) IVF frozen embryo transfer time inclusion Severe oligospermia male partner ( &lt; 500 000 sperm cell )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>medically assist procreation</keyword>
</DOC>